{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:45:27Z","timestamp":1789260327971,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","issue":"34","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":2599,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1074\/jbc.m113.482737","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T02:36:17Z","timestamp":1372473377000},"page":"24923-24934","source":"Crossref","is-referenced-by-count":50,"title":["Protein-tyrosine Phosphatase 1B Antagonized Signaling by Insulin-like Growth Factor-1 Receptor and Kinase BRK\/PTK6 in Ovarian Cancer Cells*"],"prefix":"10.1016","volume":"288","author":[{"given":"Gaofeng","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lucito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas K.","family":"Tonks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M113.482737_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.20121","article-title":"Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J. Clin"},{"key":"10.1074\/jbc.M113.482737_bib2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrc2831","article-title":"Integrating high throughput technologies in the quest for effective biomarkers for ovarian cancer","volume":"10","author":"Kulasingam","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.M113.482737_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2644","article-title":"The biology of ovarian cancer: new opportunities for translation","volume":"9","author":"Bast","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.M113.482737_bib4","doi-asserted-by":"crossref","first-page":"960327","DOI":"10.1155\/2012\/960327","article-title":"MET\/HGF signaling pathway in ovarian carcinoma: Clinical implications and future direction","volume":"2012","author":"Mhawech-Fauceglia","year":"2012","journal-title":"Pathol. Res. Int"},{"key":"10.1074\/jbc.M113.482737_bib5","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3390\/ijms14011179","article-title":"Hedgehog signaling pathway in ovarian cancer","volume":"14","author":"Szkandera","year":"2013","journal-title":"Int. J. Mol. Sci"},{"key":"10.1074\/jbc.M113.482737_bib6","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.2174\/092986711796150450","article-title":"Targeting mTOR signaling pathway in ovarian cancer","volume":"18","author":"Mabuchi","year":"2011","journal-title":"Curr. Med. Chem"},{"key":"10.1074\/jbc.M113.482737_bib7","doi-asserted-by":"crossref","first-page":"e52578","DOI":"10.1371\/journal.pone.0052578","article-title":"Targeting GRB7\/ERK\/FOXM1 signaling pathway impairs aggressiveness of ovarian cancer cells","volume":"7","author":"Chan","year":"2012","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M113.482737_bib8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.M113.482737_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3215","article-title":"The insulin and insulin-like growth factor receptor family in neoplasia: an update","volume":"12","author":"Pollak","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.M113.482737_bib10","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1158\/0008-5472.CAN-08-3153","article-title":"Hyperactivation of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of ovarian cancer cells","volume":"69","author":"Eckstein","year":"2009","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M113.482737_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1517\/14728222.2013.749863","article-title":"Targeting IGF-1 signaling pathways in gynecologic malignancies","volume":"17","author":"Bruchim","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1074\/jbc.M113.482737_bib12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nrm2039","article-title":"Protein-tyrosine phosphatases: from genes, to function, to disease","volume":"7","author":"Tonks","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/jbc.M113.482737_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrc2980","article-title":"Inside the human cancer tyrosine phosphatome","volume":"11","author":"Julien","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1074\/jbc.M113.482737_bib14","doi-asserted-by":"crossref","first-page":"6731","DOI":"10.1016\/S0021-9258(18)68703-4","article-title":"Characterization of the major protein-tyrosine-phosphatases of human placenta","volume":"263","author":"Tonks","year":"1988","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.482737_bib15","doi-asserted-by":"crossref","first-page":"6722","DOI":"10.1016\/S0021-9258(18)68702-2","article-title":"Purification of the major protein-tyrosine-phosphatases of human placenta","volume":"263","author":"Tonks","year":"1988","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.482737_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1006\/excr.1995.1184","article-title":"Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs)","volume":"218","author":"Tsao","year":"1995","journal-title":"Exp. Cell Res"},{"key":"10.1074\/jbc.M113.482737_bib17","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/oby.2009.444","article-title":"Inhibition of PTP1B by trodusquemine (MSI-1436) causes fat-specific weight loss in diet-induced obese mice","volume":"18","author":"Lantz","year":"2010","journal-title":"Obesity"},{"key":"10.1074\/jbc.M113.482737_bib18","doi-asserted-by":"crossref","first-page":"ra86","DOI":"10.1126\/scisignal.2002329","article-title":"H2S-induced sulfhydration of the phosphatase PTP1B and its role in the endoplasmic reticulum stress response","volume":"4","author":"Krishnan","year":"2011","journal-title":"Sci. Signal"},{"key":"10.1074\/jbc.M113.482737_bib19","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1021\/jm050392q","article-title":"Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity","volume":"48","author":"Wittman","year":"2005","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.M113.482737_bib20","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1073\/pnas.94.5.1680","article-title":"Development of \u201csubstrate-trapping\u201d mutants to identify physiological substrates of protein-tyrosine phosphatases","volume":"94","author":"Flint","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.482737_bib21","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4161\/cbt.5.9.2953","article-title":"The BRK tyrosine kinase is expressed in high grade serous carcinoma of the ovary","volume":"5","author":"Schmandt","year":"2006","journal-title":"Cancer Biol. Ther"},{"key":"10.1074\/jbc.M113.482737_bib22","doi-asserted-by":"crossref","first-page":"e11729","DOI":"10.1371\/journal.pone.0011729","article-title":"PTK6 regulates IGF-1-induced anchorage-independent survival","volume":"5","author":"Irie","year":"2010","journal-title":"PLoS One"},{"key":"10.1074\/jbc.M113.482737_bib23","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tibs.2010.03.004","article-title":"PTP1B: a double agent in metabolism and oncogenesis","volume":"35","author":"Yip","year":"2010","journal-title":"Trends Biochem. Sci"},{"key":"10.1074\/jbc.M113.482737_bib24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.pharmtox.42.083001.144616","article-title":"Protein-tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development","volume":"42","author":"Zhang","year":"2002","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"10.1074\/jbc.M113.482737_bib25","doi-asserted-by":"crossref","first-page":"41439","DOI":"10.1074\/jbc.M004852200","article-title":"Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines","volume":"275","author":"Bjorge","year":"2000","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.482737_bib26","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1158\/1078-0432.CCR-03-0409","article-title":"Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis","volume":"10","author":"Lu","year":"2004","journal-title":"Clin. Cancer Res"},{"key":"10.1074\/jbc.M113.482737_bib27","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1128\/MCB.22.7.1998-2010.2002","article-title":"Regulation of insulin-like growth factor type I (IGF-I) receptor kinase activity by protein-tyrosine phosphatase 1B (PTP-1B) and enhanced IGF-I-mediated suppression of apoptosis and motility in PTP-1B-deficient fibroblasts","volume":"22","author":"Buckley","year":"2002","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.M113.482737_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/mp.55.1.46","article-title":"Identification of an IGF-1R kinase regulatory phosphatase using the fission yeast Schizosaccharomyces pombe and a GFP-tagged IGF-1R in mammalian cells","volume":"55","author":"Buckley","year":"2002","journal-title":"Mol. Pathol"},{"key":"10.1074\/jbc.M113.482737_bib29","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1124\/mol.105.013151","article-title":"Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein-tyrosine phosphatase 1B using bioluminescence resonance energy transfer","volume":"68","author":"Blanquart","year":"2005","journal-title":"Mol. Pharmacol"},{"key":"10.1074\/jbc.M113.482737_bib30","first-page":"66","article-title":"Building a better understanding of the intracellular tyrosine kinase PTK6-BRK by BRK","volume":"1806","author":"Brauer","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M113.482737_bib31","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.coph.2010.08.007","article-title":"Brk\/PTK6 signaling in normal and cancer cell models","volume":"10","author":"Ostrander","year":"2010","journal-title":"Curr. Opin. Pharmacol"},{"key":"10.1074\/jbc.M113.482737_bib32","doi-asserted-by":"crossref","first-page":"34634","DOI":"10.1074\/jbc.M203877200","article-title":"Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition","volume":"277","author":"Qiu","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.482737_bib33","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1038\/sj.onc.1206465","article-title":"Altered localization and activity of the intracellular tyrosine kinase BRK\/Sik in prostate tumor cells","volume":"22","author":"Derry","year":"2003","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M113.482737_bib34","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1128\/MCB.01901-05","article-title":"Protein-tyrosine kinase 6 negatively regulates growth and promotes enterocyte differentiation in the small intestine","volume":"26","author":"Haegebarth","year":"2006","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.M113.482737_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00403-010-1118-4","article-title":"Breast tumor kinase (Brk\/PTK6) plays a role in the differentiation of primary keratinocytes","volume":"303","author":"Tupper","year":"2011","journal-title":"Arch. Dermatol. Res"},{"key":"10.1074\/jbc.M113.482737_bib36","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/sj.onc.1201292","article-title":"Characterisation and chromosome mapping of the human nonreceptor tyrosine kinase gene, brk","volume":"15","author":"Mitchell","year":"1997","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M113.482737_bib37","first-page":"2383","article-title":"Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours","volume":"9","author":"Mitchell","year":"1994","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M113.482737_bib38","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/sj.onc.1201241","article-title":"BRK tyrosine kinase expression in a high proportion of human breast carcinomas","volume":"15","author":"Barker","year":"1997","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M113.482737_bib39","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1038\/sj.onc.1206577","article-title":"Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation","volume":"22","author":"Harvey","year":"2003","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M113.482737_bib40","doi-asserted-by":"crossref","first-page":"12463","DOI":"10.1073\/pnas.0805009105","article-title":"Brk is coamplified with ErbB2 to promote proliferation in breast cancer","volume":"105","author":"Xiang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.482737_bib41","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.2353\/ajpath.2009.080811","article-title":"Brk protects breast cancer cells from autophagic cell death induced by loss of anchorage","volume":"175","author":"Harvey","year":"2009","journal-title":"Am. J. Pathol"},{"key":"10.1074\/jbc.M113.482737_bib42","doi-asserted-by":"crossref","first-page":"30956","DOI":"10.1074\/jbc.271.48.30956","article-title":"Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factor","volume":"271","author":"Kamalati","year":"1996","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.482737_bib43","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1038\/sj.onc.1203931","article-title":"Expression of the BRK tyrosine kinase in mammary epithelial cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation","volume":"19","author":"Kamalati","year":"2000","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M113.482737_bib44","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1158\/0008-5472.CAN-06-3409","article-title":"Breast tumor kinase (protein-tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells","volume":"67","author":"Ostrander","year":"2007","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M113.482737_bib45","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1039\/c0mb00286k","article-title":"Impact of protein-tyrosine kinase 6 (PTK6) on human epidermal growth factor receptor (HER) signalling in breast cancer","volume":"7","author":"Ludyga","year":"2011","journal-title":"Mol. BioSyst"},{"key":"10.1074\/jbc.M113.482737_bib46","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1038\/onc.2011.608","article-title":"Brk\/PTK6 sustains activated EGFR signaling through inhibiting EGFR degradation and transactivating EGFR","volume":"31","author":"Li","year":"2012","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M113.482737_bib47","doi-asserted-by":"crossref","first-page":"26013","DOI":"10.1074\/jbc.M109.088971","article-title":"PTK6 inhibits down-regulation of EGF receptor through phosphorylation of ARAP1","volume":"285","author":"Kang","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.482737_bib48","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/path.1720","article-title":"Simultaneous overexpression of the Her2\/neu and PTK6 tyrosine kinases in archival invasive ductal breast carcinomas","volume":"205","author":"Born","year":"2005","journal-title":"J. Pathol"},{"key":"10.1074\/jbc.M113.482737_bib49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12672-011-0097-z","article-title":"Mechanisms of HGF\/Met signaling to Brk and Sam68 in breast cancer progression","volume":"3","author":"Locatelli","year":"2012","journal-title":"Horm. Cancer"},{"key":"10.1074\/jbc.M113.482737_bib50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ceb.2005.02.001","article-title":"Cytoplasmic protein-tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP","volume":"17","author":"Bourdeau","year":"2005","journal-title":"Curr. Opin. Cell Biol"},{"key":"10.1074\/jbc.M113.482737_bib51","doi-asserted-by":"crossref","first-page":"10088","DOI":"10.1158\/0008-5472.CAN-05-1353","article-title":"Genetic ablation of protein-tyrosine phosphatase 1B accelerates lymphomagenesis of p53-null mice through the regulation of B-cell development","volume":"65","author":"Dub\u00e9","year":"2005","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M113.482737_bib52","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1158\/0008-5472.CAN-08-4001","article-title":"Activation of Src by protein-tyrosine phosphatase 1B Is required for ErbB2 transformation of human breast epithelial cells","volume":"69","author":"Arias-Romero","year":"2009","journal-title":"Cancer Res"},{"key":"10.1074\/jbc.M113.482737_bib53","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng1963","article-title":"Protein-tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis","volume":"39","author":"Julien","year":"2007","journal-title":"Nat. Genet"},{"key":"10.1074\/jbc.M113.482737_bib54","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ccr.2007.02.022","article-title":"A brake becomes an accelerator: PTP1B\u2013a new therapeutic target for breast cancer","volume":"11","author":"Tonks","year":"2007","journal-title":"Cancer Cell"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820452433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820452433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M113.482737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T09:19:16Z","timestamp":1641287956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820452433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":54,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0021925820452433"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m113.482737","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}